COST SAVINGS ASCHIEVED BY REDUCING NEED FOR CARDIAC DEVICES IN PATIENTS WITH SEVERE HEART FAILURE USING LCZ696(SACUBITRIL / VALSARTAN)
Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 10
Abstract
Background: Cardiac resynchronization therapy (CRT) with and without automatic implantable cardioverter-defibrillators (AICDs), AICDs have been recommended as class1A recommendation for a certain subset of patients with Congestive heart failure with reduced ejection fraction (CHFrEF) based on multiple major trials that showed improved mortality and morbidity with these devices, however this comes at great cost which might be unaffordable in some health systems, LCZ696 in previous publication showed improvement in ejection fraction, in this study we for the first time showed some of the cost savings this medication had contributed to by reducing the need for such devices. Materials & Methods: A chart review of patients placed on LCZ696 for clinical purposes over 36 months between 2016 and 2018. All follow-up visits were analyzed. Quality of life-based on New York Heart Association (NYHA) classification was recorded. All hospital admissions, deaths, labs, echocardiograms were recorded. Length of the study was 3months- 36 months (mean of 16 months), all patients whose charts were reviewed, signed an informed consent form allowing for this charts review. Results: 180 charts were reviewed; mean follow-up was 16 months, 14 patients (8%) died during follow-up. 29 patients(16%)stopped the medication, patients receiving LCZ 696 showed 43% improvement in EF and 41% improvement in NYHA class.(125) patients had an ejection fraction of less than 35%on initial presentations, of those (73) patients (64%) improved their ejection fraction to above 35%, and 12 patients (10%) did not have a follow-up echocardiogram, 5 patients (3%) lost follow-up. Conclusion: use of LCZ696 did improve not only quality of life but also ejection fraction resulting in a reduction in the need of devices with subsequent major health cost savings, based on our knowledge this result is the first time to be measured statistically and reported.
Authors and Affiliations
Raed Aqel MD.
Keywords
Related Articles
- EP ID EP674556
- DOI -
- Views 135
- Downloads 0
ANTIBACTERIAL ACTIVITY OF THE LEAF FRACTIONS OF ALCHORNEA CORDIFOLIA AGAINST ISOLATES FROM PATIENTS WITH RESPIRATORY TRACT INFECTION IN AHMADU BELLO UNIVERSITY TEACHING HOSPITAL ZARIA, NIGERIA
Background: Recent years have witnessed a dramatic increase in antibacterial resistance and a decline in the development of novel antibiotics. This problem is prevalent among common etiologic pathogens associated with Re...
CAN PATIENT TRAINING HELP METERED DOSE INHALER TECHNIQUE?
Asthma is a chronic inflammatory disease of the airways that affecting millions of people worldwide. Inhaled administration is the mainstay of asthma management and metered dose inhalers (MDIs) are the most widely prescr...
EFFECTS OF CURCUMA LONGA L., CURCUMA AROMATICA SALISB., ZINGIBER OFFICINALE ROSC. EXTRACT ON INFLAMMATORY TEMPOROMANDIBULAR JOINT PAIN IN RAT’S
Objective: Zingiberaceae plants(Curcuma longa L. (C.L), Curcuma aromatica Salisb. (C.A) and Zingiber officinale Rosc. (Z.O)) which are well known as effects of anti-inflammation or anti-nociception. We investigated that...
POSSIBLE EXISTENCE OF A METAMATERIAL INSIDE MICROTUBULES AND THE RESULTING EXPLANATION FOR ANESTHETIC ACTION OF SUPERLUMINAL PHOTONS UPON CONSCIOUSNESS
D. Georgiev presented an idea that consciousness could be the result of quantum computation via short laser-like pulses controlling quantum gates within the brain cortex. However, he later rejected this theory because th...
SYNTHESIS AND ANTIPLASMODIAL EVALUATION OF A NEW TRIOXAQUINE
The ultimate objective of this work was to develop a novel antimalarial hybrid drug based on quinoline and trioxane pharmacophoric scaffold that is effective against drug-resistant malaria, especially in the face of emer...